Skip to main content
OpenTrials
Completed

NCT Number: NCT06572579

A Pilot Registry for Ultrasound-guided Pharmacopuncture

A pilot study of prospective resigstry to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture for spinal disorders

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neck Pain Back Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

19 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Jaseng Hospital of Korean medicine, Seoul, Gangnam-Gu, South Korea

Loading trial locations.

About this study

This study aims to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture by collecting information on adverse reactions, efficacy assessment variables, and treatment methods from patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals diagnosed with spinal disorders (M code and S code based on KCD criteria)
  • Outpatients scheduled for ultrasound-guided pharmacopuncture treatment
  • Individuals aged 19 years or older and under 70 years
  • Individuals who agree to participate in the clinical study and voluntarily sign the consent form

Exclusion criteria

  • Individuals who are unable to complete the consent form
  • Individuals who are deemed unsuitable for participation in the clinical study by the researcher

Treatment and study plan

Ultrasound-guided pharmacopuncture treatment

Procedure

Pharmacopuncture treatment using ultrasound-guidance

Primary outcomes

  1. Adverse Event

    Time frame: Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups

    Adverse events assessment

Secondary outcomes

  1. Spinal pain numeric rating scale

    Time frame: Week 0, Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups

    Spinal pain numeric rating scale

  2. Disability index

    Time frame: Week 0, 2, 4, 8, 12

    Neck disability index or Oswestry Disability Index

  3. EQ-5D-5L

    Time frame: Week 0, 2, 4, 8, 12

    Quality of life using EQ-5D-5L

  4. Patient satisfaction

    Time frame: Week 4

    Patient satisfaction survey

Sponsors and collaborators

Lead sponsor

Jaseng Medical Foundation

Other

Registry information

Official study title

Safety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases: A Pilot Registry

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Aug 27, 2024
Registry last updated
Oct 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.